INGN Q4 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$82M+2.0% YoY

Gross Profit

$41M50.4% margin

Operating Income

-$9M-11.4% margin

Net Income

-$7M-8.7% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

-11.5%

Cash Flow

Operating Cash Flow

-$943,000

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$299M

Total Liabilities

$106M

Stockholders' Equity

$192M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$80M	+2.0%
Gross Profit	$41M	$36M	+13.6%
Operating Income	-$9M	-$11M	+18.3%
Net Income	-$7M	-$10M	+27.0%

Geographic Segments

UNITED STATES

$49M60%

Non-US

$33M40%